chartexchange

FHTX
Foghorn Therapeutics Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:54 PM EST
2.07USD+0.732%(+0.02)534,219
After-hoursNov 13, 2026 4:00:30 PM EST
2.07USD+0.242%(+0.00)
Loading…
Loading…
123.82M
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$2.05
Beta
1.63
52-Week High
$7.61 2026-08-20
52-Week Low
$1.79 2026-10-01
SMA 50
$2.84
SMA 200
$4.53
Avg. Vol 10D
800,207
Avg. Vol 30D
800,764
Avg. Vol 90D
645,288
Relative Vol
0.67
25.83M
0.5200%
14,493
FHTX Profile

foghorn therapeutics inc., a biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. the company uses its proprietary gene traffic control platform to identify, validate, and potentially drug targets within the system. it is developing fhd-286, a small-molecule enzymatic inhibitor of brg1 and brm for the treatment of acute myeloid leukemia and uveal melanoma; and fhd-609, a small molecule protein degrader of brd9 to treat patients with synovial sarcoma. the company is also developing preclinical and discovery programs, including selective brm targeting non-small-cell lung cancer; and selective arid1b modulators for bladder, ovarian, and endometrial cancer. it has a collaboration with merck sharp & dohme corp. to discover and develop novel oncology therapeutics against a transcription factor target. the company was founded in 2015 and is headquartered in cambridge, massachusetts.

FHTX Performance
PeriodPriceDateChangeBeta
1W1.872026-11-06+10.43%5.599
1M1.852026-10-13+11.62%2.308
3M6.492026-08-13-68.18%1.084
6M4.172026-05-13-50.48%1.290
1Y4.362025-11-13-52.64%1.625
2Y8.852024-11-13-76.67%—
5Y14.632021-11-12-85.89%1.566
FHTX Stock Summary

Foghorn Therapeutics Inc. Common Stock (NASDAQ:FHTX) stock price today is $2.07, and today's volume is 534,219. FHTX is up 0.732% today. The 30 day average volume is 800,764. FHTX market cap is $123.82M with 59.96M shares outstanding.